Hair loss is a widespread issue, often causing significant distress. While some embrace baldness as "the new sexy," many ...

A receding hairline may be common — about two-thirds of men start losing their hair by age 35 — but that doesn’t make it any ...

A young woman began noticing bald patches on her head last year and discovered she had alopecia - now she is on a mission to ...

Panelists discuss how the introduction of Janus kinase (JAK) inhibitor therapies will likely change treatment algorithms for alopecia areata (AA), with insights on how payers should plan for coverage ...

Panelists discuss how the Bayesian network meta-analysis showed which Janus kinase (JAK) inhibitors were most effective in ...

Alopecia areata, ringworm, and chemotherapy are among the most common causes of a bald spot or patch in the beard. Treatment can vary depending on the underlying cause of a bald patch in the beard.

By the age of 50, nearly 50% of men and 25% of women experience significant hair loss.” – American Academy of Dermatology ...

Convenient, pain-free, and drug-free, red light hair-growth devices are quickly becoming a go-to treatment for hair loss—so ...

Thinning hair is reversible and can fill out again, depending on the cause. Learn about hormonal hair loss, the role of ...

Alopecia areata affects nearly 1 in 1,000 people ... the psychological health and quality of life of patients. Current treatments focus on symptom management rather than providing a consistent ...

Q32 Bio has put a stop to a Phase II trial of its former lead renal disease candidate as it pivots focus over to its alopecia areata treatment, bempikibart, amid a corporate restructure and job cuts.